78 results
Page 2 of 4
8-K
EX-1.1
n14i19e8rlkjd8zya
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
dolt5dh
13 Sep 22
Regulation FD Disclosure
9:07am
8-K
EX-10.1
za7o8be0e ntgpmu
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am
8-K
kgza t2a65bl5
8 Jun 22
Regulation FD Disclosure
9:06am
8-K
ukm6g
9 Sep 21
A Global Disease, A Pioneering Treatment Corporate Presentation September 2021
4:46pm
S-3ASR
EX-4.4
47tuuhqd
18 May 21
Automatic shelf registration
6:01am
S-3ASR
EX-1.2
04fobjczx 217utt71
18 May 21
Automatic shelf registration
6:01am
S-3ASR
EX-4.3
hnfd6pep
18 May 21
Automatic shelf registration
6:01am
8-K
g9dh m6492futia
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
j1xdh
13 Apr 21
A Global Disease, A Pioneering Treatment Corporate Presentation April 2021
8:30am
8-K
w19u527x
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm